Saturday, December 6, 2014

Is Competition for Sun's Liposomal doxorubicin in the US on the anvil!

Dr. Reddy has initiated a bioeqivalence trial comparing its generic version of Liposomal doxorubicin to Sun pharma's generic copy of Liposomal doxorubicin. The study will complete in February 2015. It is speculated that Dr. Reddy has partnership with Natco Pharma for the development of liposomal doxorubicin. If everything falls in place in time an approval for Reddy's generic copy of liposomal doxorubicin should come in as early as YE 2015.
Enter your email address:


Delivered by FeedBurner